PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
1322666-4	1992	DDTC treatment also increased interleukin-alpha (IL-1 alpha), IL-1 beta, and tumor necrosis factor (TNF) expression in these cells.	Ditiocarb	0-4	interleukin 1 alpha	Homo sapiens	49-59	
1322666-4	1992	DDTC treatment also increased interleukin-alpha (IL-1 alpha), IL-1 beta, and tumor necrosis factor (TNF) expression in these cells.	Ditiocarb	0-4	interleukin 1 beta	Homo sapiens	62-71	
1322666-4	1992	DDTC treatment also increased interleukin-alpha (IL-1 alpha), IL-1 beta, and tumor necrosis factor (TNF) expression in these cells.	Ditiocarb	0-4	tumor necrosis factor	Homo sapiens	77-98	
1322666-4	1992	DDTC treatment also increased interleukin-alpha (IL-1 alpha), IL-1 beta, and tumor necrosis factor (TNF) expression in these cells.	Ditiocarb	0-4	tumor necrosis factor	Homo sapiens	100-103	
1322666-8	1992	Transcriptional run-on analysis demonstrated that exposure to DDTC increased the rate of TNF gene transcription in HL-60 cells.	Ditiocarb	62-66	tumor necrosis factor	Homo sapiens	89-92	
1322666-9	1992	These data suggest that the myeloprotective effects of DDTC may be mediated, at least in part, by the induction of TNF, IL-1 alpha, and IL-1 beta.	Ditiocarb	55-59	tumor necrosis factor	Homo sapiens	115-118	
1322666-9	1992	These data suggest that the myeloprotective effects of DDTC may be mediated, at least in part, by the induction of TNF, IL-1 alpha, and IL-1 beta.	Ditiocarb	55-59	interleukin 1 alpha	Homo sapiens	120-130	
1322666-9	1992	These data suggest that the myeloprotective effects of DDTC may be mediated, at least in part, by the induction of TNF, IL-1 alpha, and IL-1 beta.	Ditiocarb	55-59	interleukin 1 beta	Homo sapiens	136-145